Benatti Luca (CIK 1613842) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-29). Recent activity: Buy QNCX (8,918 shares), Sell QNCX (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-29 | Quince Therapeutics, Inc. (QNCX) | Director | Buy | 8,918 | $0 |
| 2025-12-29 | Quince Therapeutics, Inc. (QNCX) | Director | Sell | 50,000 | $173,500 |
Source: SEC Form 4 filings · as of 2025-12-29